250 related articles for article (PubMed ID: 23991698)
1. Anandamide transport inhibition by ARN272 attenuates nausea-induced behaviour in rats, and vomiting in shrews (Suncus murinus).
O'Brien LD; Limebeer CL; Rock EM; Bottegoni G; Piomelli D; Parker LA
Br J Pharmacol; 2013 Nov; 170(5):1130-6. PubMed ID: 23991698
[TBL] [Abstract][Full Text] [Related]
2. Tetrahydrocannabinolic acid reduces nausea-induced conditioned gaping in rats and vomiting in Suncus murinus.
Rock EM; Kopstick RL; Limebeer CL; Parker LA
Br J Pharmacol; 2013 Oct; 170(3):641-8. PubMed ID: 23889598
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of monoacylglycerol lipase attenuates vomiting in Suncus murinus and 2-arachidonoyl glycerol attenuates nausea in rats.
Sticht MA; Long JZ; Rock EM; Limebeer CL; Mechoulam R; Cravatt BF; Parker LA
Br J Pharmacol; 2012 Apr; 165(8):2425-35. PubMed ID: 21470205
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of anticipatory nausea in a rat model of contextually elicited conditioned gaping by enhancement of the endocannabinoid system.
Limebeer CL; Abdullah RA; Rock EM; Imhof E; Wang K; Lichtman AH; Parker LA
Psychopharmacology (Berl); 2014 Feb; 231(3):603-12. PubMed ID: 24043345
[TBL] [Abstract][Full Text] [Related]
5. Cannabidiolic acid prevents vomiting in Suncus murinus and nausea-induced behaviour in rats by enhancing 5-HT1A receptor activation.
Bolognini D; Rock EM; Cluny NL; Cascio MG; Limebeer CL; Duncan M; Stott CG; Javid FA; Parker LA; Pertwee RG
Br J Pharmacol; 2013 Mar; 168(6):1456-70. PubMed ID: 23121618
[TBL] [Abstract][Full Text] [Related]
6. Effects of the FAAH inhibitor, URB597, and anandamide on lithium-induced taste reactivity responses: a measure of nausea in the rat.
Cross-Mellor SK; Ossenkopp KP; Piomelli D; Parker LA
Psychopharmacology (Berl); 2007 Feb; 190(2):135-43. PubMed ID: 17111174
[TBL] [Abstract][Full Text] [Related]
7. The FAAH inhibitor URB-597 interferes with cisplatin- and nicotine-induced vomiting in the Suncus murinus (house musk shrew).
Parker LA; Limebeer CL; Rock EM; Litt DL; Kwiatkowska M; Piomelli D
Physiol Behav; 2009 Apr; 97(1):121-4. PubMed ID: 19239915
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the potential of the phytocannabinoids, cannabidivarin (CBDV) and Δ(9) -tetrahydrocannabivarin (THCV), to produce CB1 receptor inverse agonism symptoms of nausea in rats.
Rock EM; Sticht MA; Duncan M; Stott C; Parker LA
Br J Pharmacol; 2013 Oct; 170(3):671-8. PubMed ID: 23902479
[TBL] [Abstract][Full Text] [Related]
9. 2-arachidonoylglycerol interferes with lithium-induced vomiting in the house musk shrew, Suncus murinus.
Sticht MA; Rock EM; Parker LA
Physiol Behav; 2013 Aug; 120():228-32. PubMed ID: 23958470
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of cue-induced reinstatement of nicotine seeking by URB597 through cannabinoid CB1 receptor in rats.
Forget B; Guranda M; Gamaleddin I; Goldberg SR; Le Foll B
Psychopharmacology (Berl); 2016 May; 233(10):1823-8. PubMed ID: 26864774
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoid 2 (CB2) receptor agonism reduces lithium chloride-induced vomiting in Suncus murinus and nausea-induced conditioned gaping in rats.
Rock EM; Boulet N; Limebeer CL; Mechoulam R; Parker LA
Eur J Pharmacol; 2016 Sep; 786():94-99. PubMed ID: 27263826
[TBL] [Abstract][Full Text] [Related]
12. Inverse agonism of cannabinoid CB1 receptors potentiates LiCl-induced nausea in the conditioned gaping model in rats.
Limebeer CL; Vemuri VK; Bedard H; Lang ST; Ossenkopp KP; Makriyannis A; Parker LA
Br J Pharmacol; 2010 Sep; 161(2):336-49. PubMed ID: 20735419
[TBL] [Abstract][Full Text] [Related]
13. Cannabidiol, a non-psychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT(1A) somatodendritic autoreceptors in the dorsal raphe nucleus.
Rock EM; Bolognini D; Limebeer CL; Cascio MG; Anavi-Goffer S; Fletcher PJ; Mechoulam R; Pertwee RG; Parker LA
Br J Pharmacol; 2012 Apr; 165(8):2620-34. PubMed ID: 21827451
[TBL] [Abstract][Full Text] [Related]
14. The anti-nausea effects of CB1 agonists are mediated by an action at the visceral insular cortex.
Limebeer CL; Rock EM; Mechoulam R; Parker LA
Br J Pharmacol; 2012 Nov; 167(5):1126-36. PubMed ID: 22671779
[TBL] [Abstract][Full Text] [Related]
15. Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors.
Moreira FA; Kaiser N; Monory K; Lutz B
Neuropharmacology; 2008 Jan; 54(1):141-50. PubMed ID: 17709120
[TBL] [Abstract][Full Text] [Related]
16. Interference with acute nausea and anticipatory nausea in rats by fatty acid amide hydrolase (FAAH) inhibition through a PPARα and CB1 receptor mechanism, respectively: a double dissociation.
Rock EM; Limebeer CL; Ward JM; Cohen A; Grove K; Niphakis MJ; Cravatt BF; Parker LA
Psychopharmacology (Berl); 2015 Oct; 232(20):3841-8. PubMed ID: 26297326
[TBL] [Abstract][Full Text] [Related]
17. The endogenous cannabinoid anandamide produces delta-9-tetrahydrocannabinol-like discriminative and neurochemical effects that are enhanced by inhibition of fatty acid amide hydrolase but not by inhibition of anandamide transport.
Solinas M; Tanda G; Justinova Z; Wertheim CE; Yasar S; Piomelli D; Vadivel SK; Makriyannis A; Goldberg SR
J Pharmacol Exp Ther; 2007 Apr; 321(1):370-80. PubMed ID: 17210800
[TBL] [Abstract][Full Text] [Related]
18. Anti-aversive role of the endocannabinoid system in the periaqueductal gray stimulation model of panic attacks in rats.
Viana TG; Hott SC; Resstel LB; Aguiar DC; Moreira FA
Psychopharmacology (Berl); 2015 May; 232(9):1545-53. PubMed ID: 25388290
[TBL] [Abstract][Full Text] [Related]
19. The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition.
Scherma M; Medalie J; Fratta W; Vadivel SK; Makriyannis A; Piomelli D; Mikics E; Haller J; Yasar S; Tanda G; Goldberg SR
Neuropharmacology; 2008 Jan; 54(1):129-40. PubMed ID: 17904589
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoid CB
Leonard MZ; Alapafuja SO; Ji L; Shukla VG; Liu Y; Nikas SP; Makriyannis A; Bergman J; Kangas BD
J Pharmacol Exp Ther; 2017 Dec; 363(3):314-323. PubMed ID: 28947487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]